Harbord MW - Search Results

1

Percutaneous gastrostomy: troubleshooting complications.

Lepore M, Marks DJ, Harbord MW. Lepore M, et al. Among authors: harbord mw. Br J Hosp Med (Lond). 2016 Jun;77(6):C86-90. doi: 10.12968/hmed.2016.77.6.C86. Br J Hosp Med (Lond). 2016. PMID: 27269765 Free article. Review. No abstract available.

2

Defective acute inflammation in Crohn's disease: a clinical investigation.

Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, Lees W, Novelli M, Bloom S, Segal AW. Marks DJ, et al. Among authors: harbord mw. Lancet. 2006 Feb 25;367(9511):668-78. doi: 10.1016/S0140-6736(06)68265-2. Lancet. 2006. PMID: 16503465

3

Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor.

Harbord MW, Marks DJ, Forbes A, Bloom SL, Day RM, Segal AW. Harbord MW, et al. Aliment Pharmacol Ther. 2006 Aug 15;24(4):651-60. doi: 10.1111/j.1365-2036.2006.03016.x. Aliment Pharmacol Ther. 2006. PMID: 16907898 Free PMC article.

4

Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans.

Day RM, Harbord M, Forbes A, Segal AW. Day RM, et al. J Immunol Methods. 2001 Nov 1;257(1-2):213-20. doi: 10.1016/s0022-1759(01)00467-7. J Immunol Methods. 2001. PMID: 11687254

5

Ym1 is a neutrophil granule protein that crystallizes in p47phox-deficient mice.

Harbord M, Novelli M, Canas B, Power D, Davis C, Godovac-Zimmermann J, Roes J, Segal AW. Harbord M, et al. J Biol Chem. 2002 Feb 15;277(7):5468-75. doi: 10.1074/jbc.M110635200. Epub 2001 Dec 3. J Biol Chem. 2002. PMID: 11733538 Free article.

6

Association between p47phox pseudogenes and inflammatory bowel disease.

Harbord M, Hankin A, Bloom S, Mitchison H. Harbord M, et al. Blood. 2003 Apr 15;101(8):3337. doi: 10.1182/blood-2002-10-3060. Blood. 2003. PMID: 12672696 Free article. No abstract available.

7

Conditional haploinsufficiency of NCF1 (encoding p47(phox)), a signaling gene with a heterozygous phenotype potentially subject to natural selection.

Mitchison NA, Harbord M, Hankin A, Roes J. Mitchison NA, et al. Immunol Lett. 2005 Feb 15;97(1):63-7. doi: 10.1016/j.imlet.2004.09.015. Immunol Lett. 2005. PMID: 15626477

8

Immunisation against Japanese encephalitis.

Bonington A, Harbord M, Davidson RN, Cropley I, Behrens RH. Bonington A, et al. Lancet. 1995 Jun 3;345(8962):1445-6. doi: 10.1016/s0140-6736(95)92636-4. Lancet. 1995. PMID: 7760642 No abstract available.

9

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group. Sandborn WJ, et al. N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572. N Engl J Med. 2012. PMID: 23075178 Free article. Clinical Trial.

10

Different susceptibilities of PECAM-deficient mouse strains to spontaneous idiopathic pneumonitis.

Schenkel AR, Chew TW, Chlipala E, Harbord MW, Muller WA. Schenkel AR, et al. Among authors: harbord mw. Exp Mol Pathol. 2006 Aug;81(1):23-30. doi: 10.1016/j.yexmp.2005.11.007. Epub 2006 Feb 2. Exp Mol Pathol. 2006. PMID: 16457810 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page